Efficacy of Home-Based Hypertension Management in Rural South Africa

A groundbreaking study shows that home-based, technology-supported hypertension management significantly improves blood pressure control in rural South African communities, offering a scalable solution to bridge healthcare gaps.
Recent research presented at the ESC Congress 2025 and published in the New England Journal of Medicine highlights the promising impact of home-based hypertension care in rural South Africa. Hypertension, a leading risk factor for stroke and cardiovascular diseases in South Africa, remains poorly controlled despite the availability of affordable treatments. Barriers such as lack of patient confidence, overcrowded clinics, long waiting times, and transportation costs hinder effective management.
The IMPACT-BP trial, conducted at the Africa Health Research Institute in KwaZulu-Natal, investigated whether technology-supported home interventions could improve blood pressure control. The trial recruited 774 adults with uncontrolled hypertension, defined by systolic BP >140 mmHg and/or diastolic BP >90 mmHg, with participants randomized into three groups:
- Standard clinic-based hypertension management.
 - Home-based BP self-monitoring assisted by community health workers, who performed home visits for data collection and medication delivery, with remote nurse-led care supported by a mobile app.
 - An enhanced community health worker group using cellular technology to transmit BP readings automatically to a mobile application.
 
The study's primary measure was the change in systolic blood pressure over six months. Results showed significant reductions in systolic BP in both home-based groups compared to standard care. The community health worker group saw an average decrease of 7.9 mmHg, while the enhanced group experienced an even greater reduction of 9.1 mmHg. Hypertension control rates improved from 57.6% with usual care to over 80% with home-based interventions. Notably, these gains persisted at the 12-month mark.
Importantly, the intervention groups maintained high retention rates (>95%) and reported positive experiences with self-managing their condition. Severe adverse events and deaths were rare and similar across all groups, indicating safety.
Experts emphasized that shifting chronic disease management from the clinic to the patient's home can significantly improve outcomes, especially in underserved communities. The success of this model demonstrates that equitable healthcare access and effective hypertension control are achievable in resource-limited rural settings. Future efforts may expand such programs to include management of multiple conditions and address additional structural barriers.
This study underscores the potential for innovative, patient-centered approaches to tackle hypertension and reduce cardiovascular risk in disadvantaged, remote communities.
Source: https://medicalxpress.com/news/2025-09-home-based-hypertension-effective-rural.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Rapid Genetic Testing Reveals Hidden Cases of Rare Immune Disorders
A new innovative genetic testing method accelerates diagnosis of rare immune disorders like APDS, uncovering hidden cases and potential new prevalence among the population.
Research Links Environmental Chemicals to Changes in Genital Development in Young Children
New research indicates that exposure to phthalates may affect genital development in children, potentially impacting reproductive health later in life. This study highlights the importance of reducing exposure to these common endocrine-disrupting chemicals.
The Role of Fetal Autopsies in Preventing Stillbirths and Addressing Society’s Blame
Fetal autopsies are essential for understanding and preventing stillbirths but are underutilized and wrongly used to blame mothers, especially in criminal cases. Improving access and expertise is key to better outcomes.
Long-Term Cardiac Microvascular Changes in Severe COVID-19 Survivors
Severe COVID-19 survivors may experience prolonged cardiac microvascular dysfunction, impacting blood flow and heart function. New research underscores the importance of understanding these lasting effects for better treatment options.



